1 citations
,
November 2025 in “Molecules” This review highlights the potential of ellagic acid for treating various skin conditions due to its antioxidant, anti-inflammatory, and depigmenting properties, but notes that novel formulations are needed to overcome its poor solubility and skin permeability to enhance clinical efficacy.
November 2025 in “Frontiers in Endocrinology” This review examines the potential of apigenin and ellagic acid as adjunct or alternative treatments for PCOS, but reports no new clinical results and highlights the need for further trials to confirm their efficacy and optimize dosing and delivery.
April 2024 in “Journal of ethnopharmacology” This study demonstrated that ellagic acid promoted hair regrowth in a DHT-induced androgenic alopecia mouse model by inhibiting ferroptosis through the activation of the Wnt/β-catenin signaling pathway, suggesting its potential as a treatment for androgenic alopecia.
March 2020 in “Asian journal of biological sciences” In this study, ellagic acid showed promise in reversing hair loss and promoting hair regrowth in male rats with testosterone-induced androgenetic alopecia, with effects comparable to the standard treatment, Minoxidil.
2 citations
,
January 2019 in “Asian journal of pharmaceutical and clinical research” This review examines the phytochemistry and pharmacology of Emblica officinalis, highlighting its traditional and documented medicinal uses, but reports no new clinical findings.